Stevanato Group and Aptar Pharma Collaborate to Help Accelerate Pre-Filled Syringe System Selection
Business Wire•27/10/2026•07:00 ET
0
Key Highlights
- ➤Stevanato Group and Aptar Pharma launch joint pre-filled syringe system testing collaboration
- ➤Evaluations cover 1 mL long and 2.25 mL syringe formats
- ➤Testing combines Stevanato EZ-fill Nexa and Alba platforms with Aptar components
- ➤Data packages assess needle-shield, plunger-force, and container-closure performance
- ➤Collaboration targets earlier packaging decisions for sensitive biologics and injectable therapies
Expert Statements
Riccardo Marcon, Senior Vice President, Sales & Marketing of Drug Containment Solutions at Stevanato Group
“As injectable therapies become increasingly complex, pharmaceutical companies need greater confidence in how packaging components perform together as complete systems.”
Riccardo Marcon, Senior Vice President, Sales & Marketing of Drug Containment Solutions at Stevanato Group
“By combining our expertise in prefillable containment solutions with Aptar Pharma's expertise in elastomeric components, we can provide customers with valuable system-level insights that support feasibility assessments, risk evaluation and more informed development decisions.”
Audrey Chardonnet, VP Global Market Development Injectables, Aptar Pharma
“We value our long-standing collaboration with Stevanato Group and the opportunity to bring our complementary expertise together at the assembled-system level.”
Audrey Chardonnet, VP Global Market Development Injectables, Aptar Pharma
“Through this joint work, we aim to provide pharmaceutical teams with earlier insight into component interactions and system performance to support informed development decisions.”
Stevanato Group and Aptar Pharma Collaborate to Help Accelerate Pre-Filled Syringe System Selection
Joint system-level testing combines Stevanato Group’s glass syringes with Aptar Pharma’s elastomer components to provide key data earlier in development and help inform packaging decisions for sensitive biologics and other injectable therapies
Get started
Create a free account to read the full story.